001     886135
005     20210130010610.0
024 7 _ |a 10.1021/acscatal.0c01789
|2 doi
024 7 _ |a 2128/26105
|2 Handle
024 7 _ |a altmetric:83713011
|2 altmetric
024 7 _ |a WOS:000551549800035
|2 WOS
037 _ _ |a FZJ-2020-04296
082 _ _ |a 540
100 1 _ |a Wehrmann, Matthias
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Engineered PQQ-Dependent Alcohol Dehydrogenase for the Oxidation of 5-(Hydroxymethyl)furoic Acid
260 _ _ |a Washington, DC
|c 2020
|b ACS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1605004492_16238
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Biotechnologie 1
520 _ _ |a Furan-2,5-dicarboxylic acid (FDCA) is a bio-based platform chemical with the potential to replace terephthalic acid in the production of polymers. A critical step for enzymatic and whole-cell production of FDCA from 5-(hydroxymethyl)furfural (HMF) is the transformation of 5-(hydroxymethyl)furoic acid (HMFA) into 5-formylfuroic acid (FFA). Here, we establish periplasmic pyrroloquinoline quinone (PQQ)-dependent alcohol dehydrogenases (ADHs) as biocatalytic tools for the oxidation of HMFA, HMF, and 5-formylfurfural (FFF). Further, we identify several amino acid residues including the “lid loop” of the substrate channel as promising targets for future engineering steps toward a fully periplasmic oxidation pathway to FDCA.
536 _ _ |a 581 - Biotechnology (POF3-581)
|0 G:(DE-HGF)POF3-581
|c POF3-581
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Elsayed, Eslam M.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Köbbing, Sebastian
|0 0000-0002-4606-4961
|b 2
700 1 _ |a Bendz, Laura
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Lepak, Alexander
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Schwabe, Johannes
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Wierckx, Nick
|0 P:(DE-Juel1)176653
|b 6
700 1 _ |a Bange, Gert
|0 P:(DE-HGF)0
|b 7
|e Corresponding author
700 1 _ |a Klebensberger, Janosch
|0 0000-0003-2740-3769
|b 8
|e Corresponding author
773 _ _ |a 10.1021/acscatal.0c01789
|g Vol. 10, no. 14, p. 7836 - 7842
|0 PERI:(DE-600)2584887-2
|n 14
|p 7836 - 7842
|t ACS catalysis
|v 10
|y 2020
|x 2155-5435
856 4 _ |y Published on 2020-06-09. Available in OpenAccess from 2021-06-09.
|z StatID:(DE-HGF)0510
|u https://juser.fz-juelich.de/record/886135/files/Wierckx%20authorcopy_ACS%20Catalysis_An%20engineered%20PQQ-dependent%20HMFA.pdf
856 4 _ |y Restricted
|u https://juser.fz-juelich.de/record/886135/files/acscatal.0c01789.pdf
856 4 _ |y Published on 2020-06-09. Available in OpenAccess from 2021-06-09.
|x pdfa
|z StatID:(DE-HGF)0510
|u https://juser.fz-juelich.de/record/886135/files/Wierckx%20authorcopy_ACS%20Catalysis_An%20engineered%20PQQ-dependent%20HMFA.pdf?subformat=pdfa
856 4 _ |y Restricted
|x pdfa
|u https://juser.fz-juelich.de/record/886135/files/acscatal.0c01789.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:886135
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)176653
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-581
|2 G:(DE-HGF)POF3-500
|v Biotechnology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-17
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACS CATAL : 2018
|d 2020-01-17
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ACS CATAL : 2018
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-17
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21